The Safety of Docetaxel with Cyclophosphamide (TC) Therapy as Adjuvant Chemotherapy for Japanese Women with Operable Breast Cancer

TASHIRO HIDEYA; SAGAWA TEIRI; OKADA KENZO; KUROKAWA TATSUO; SOGA HIROYUKI; WATANABE RYOHEI; YASUOKA YASUO; HONDA KAZUO; WATANABE YUJI; GANGI JUN'ICHI; AKEHI SHUN; MASUDA JUN; NOMOTO MASAHIRO

Art

J-GLOBAL ID：200902276123205801 Reference number：07A0267904

The Safety of Docetaxel with Cyclophosphamide (TC) Therapy as Adjuvant Chemotherapy for Japanese Women with Operable Breast Cancer

乳癌術後補助化学療法におけるDocetaxel+Cyclophosphamide(TC)療法の安全性

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=07A0267904&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0267904&from=J-GLOBAL&jstjournalNo=Z0938A") }}

Author (13)： , , , , , , , , , , , ,
Material：
Volume： 34 Issue： 3 Page： 393-396 Publication year： Mar. 15, 2007
JST Material Number： Z0938A ISSN： 0385-0684 Document type： Article
Article type：原著論文 Country of issue： Japan (JPN) Language： JAPANESE (JA)

,...
,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0267904&from=J-GLOBAL&jstjournalNo=Z0938A") }}

Clinical application of antitumor(=antineoplastic)drugs , Drug therapy(=pharmacotherapy)for tumors , Poisoning in general

Reference (11)：

Early Breast Cancer Trialist’ Collaborative Group: Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomized trials. Lancet 365: 1687-1717, 2005.
Vogel CL: Adjuvant Taxanes. American Society of Clinical Oncology Educational Book: 58-64, 2003.
Crown J: Adjuvant systemic chemotherapy of patients with node-positive breast cancer. American Society of Clinical Oncology Educational Book: 28-35, 2004.
Jones SE, Savin MA, Holmes FA, et al: Final analysis: TC (docetaxel/cyclophosphamide, 4 cycles) has a superior disease-free survival compared to standard AC (doxorubicin/cyclophosphamide) in 1016 women with early stage breast cancer. Breast Cancer Res Treat 94 (supp/1): S 20, Abs: 0040, 2005.
Hayes DF: Chemotherapy for metastatic breast can cer I. UpToDate^® 13(2): 1-10, 2005.

ｍore...

, , , ,

Return to Previous Page